Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options

TheNewsWire April 20, 2021

Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology

TheNewsWire April 19, 2021

Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference

TheNewsWire April 15, 2021

Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System

TheNewsWire April 13, 2021

Ventripoint JV Begins Process to have Heart Analysis System Certified for use in COVID Patients in China

TheNewsWire March 16, 2021

Ventripoint Passes Regulatory Inspection of Manufacturing Facility and Audit of Quality Assurance System

TheNewsWire March 9, 2021

Ventripoint Announces Extension Warrants from March 23, 2021 to May 23, 2021

TheNewsWire March 3, 2021

Ventripoint Diagnostics Receives Additional Innovation Assistance Program Funding and Updates Warrant Exercises

TheNewsWire March 3, 2021

Ventripoint JV Begins Training Chinese Cardiologists in Heart Analysis System and Achieves Milestone of First Commercial Sales

TheNewsWire March 2, 2021

Correction - Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest

TheNewsWire February 24, 2021

Ventripoint Heart Analysis System to be used at the Stollery Children's Hospital to Study Atrial Dysfunction in Children

TheNewsWire February 23, 2021

Ventripoint Advances Sales, Marketing, and Distribution Partnership in the Largest Market in World for Heart Disease: China

TheNewsWire February 16, 2021

Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest

TheNewsWire February 10, 2021

Ventripoint Diagnostics Upgrades Investor Relations Webpage

TheNewsWire February 9, 2021

Correction: Ventripoint Accelerated Expiry Date of Warrants

TheNewsWire February 8, 2021

Ventripoint Issues Option Grants

TheNewsWire February 8, 2021

Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services

TheNewsWire February 5, 2021

Ventripoint Announces Complete Conversion of Secured Convertible Debentures, Exercise of Warrants and Accelerated Expiry Date of Warrants

TheNewsWire February 3, 2021

Ventripoint Issues Option Grants and Exercises

TheNewsWire January 27, 2021

Ventripoint Diagnostics Issues Shares in Payment of Consulting Fees

TheNewsWire January 18, 2021